CHEK1 and lung carcinoma: Given the important role of CHK1 in both S- and G2-phase cell cycle arrests and in cell survival [19–22], it is likely that preventing DNA damage-caused CHK1 activation contributes to the mechanism through which triptolide increases cisplatin-induced apoptosis of these lung cancer cells.